Showing results (1-10 of 100) with videos related to
Sort By:
Pageof 10
Cell Cycle (Georgetown, Tex.)|March 16, 2011
Silencing FLIP(L) modifies TNF-induced apoptotic protein expressionLyubov Zaitseva, Stuart A Rushworth, David J MacEwanOncotarget|February 11, 2011
FLIP regulation of HO-1 and TNF signalling in human acute myeloid leukemia provides a unique secondary anti-apoptotic mechanismStuart A Rushworth, Lyubov Zaitseva, Susana Langa, et al.Cell Cycle (Georgetown, Tex.)|June 14, 2013
Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expressionMegan Y Murray, Stuart A Rushworth, Lyubov Zaitseva, et al.Blood|December 6, 2013
Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemiaStuart A Rushworth, Megan Y Murray, Lyubov Zaitseva, et al.Oncotarget|September 14, 2011
Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1Sally-Anne Heasman, Lyubov Zaitseva, Kristian M Bowles, et al.Cellular Signalling|September 15, 2012
BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κBStuart A Rushworth, Kristian M Bowles, Lawrence N Barrera, et al.American Journal of Cancer Research|December 30, 2011
Understanding the role of miRNA in regulating NF-κB in blood cancerStuart A Rushworth, Megan Y Murray, Lawrence N Barrera, et al.Blood|October 19, 2012
The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistanceStuart A Rushworth, Lyubov Zaitseva, Megan Y Murray, et al.Scientific Reports|August 22, 2015
Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemiaGenevra Pillinger, Amina Abdul-Aziz, Lyubov Zaitseva, et al.Biochemical Society Transactions|August 12, 2014
Understanding life and death decisions in human leukaemiasDavid J MacEwan, Lawrence N Barrera, Sujitra Keadsanti, et al.Pageof 10